Brochure | October 26, 2026

Oral Dose Manufacturing Capabilities: Solutions For Your Oral Dose Challenges

science laboratory research, healthcare innovation, development, investigation-GettyImages-1751659695

Changing suppliers between clinical supply and commercial launch means requalification and a risky hand-off. Jabil Healthcare's CDMO runs oral dose programs from Phase I to commercial supply on one campus, under one quality system and one accountable team. Capabilities extend to SafeBridge Category 4 potent compounds, DEA Schedule I-V substances and multi-API products, with modified release, solubility enhancement and taste-masking among the formulation options. Equipment detail is specific: blending from about 1kg to 700kg, tableting up to 216,000 per hour, encapsulation up to 48,000 per hour.

Check the equipment tables and lifecycle matrix against your batch scale and dosage form.

Access The Brochure!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Delivery Leader? Subscribe today.

Subscribe to Drug Delivery Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Drug Delivery Leader